{
  "primary": "HSP90AA1",
  "interaction_type": "indirect",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 interacts with the HSP90/CDC37 chaperone complex, which is crucial for regulating client proteins involved in protein quality control. This interaction has been confirmed by co-immunoprecipitation.",
  "functions": [
    {
      "function": "Chaperone-Mediated Protein Stability",
      "arrow": "activates",
      "cellular_process": "ATXN3 interacts with the HSP90/CDC37 chaperone complex, a critical component of the cellular protein quality control system. This machinery is responsible for the proper folding, maturation, and stability of a wide array of client proteins, particularly protein kinases. The complex can either refold misfolded proteins or target them for proteasomal degradation.",
      "effect_description": "By binding to the HSP90/CDC37 complex, ATXN3 is linked to the core machinery governing protein homeostasis. In the context of polyglutamine diseases, this interaction is relevant as the HSP90 chaperone system is known to stabilize misfolded and aggregation-prone proteins, such as the mutant, polyQ-expanded form of ATXN3, thereby potentially hindering its clearance and promoting aggregation.",
      "biological_consequence": [
        "ATXN3 interacts with the HSP90/CDC37 chaperone complex → The complex binds to various client proteins (including kinases and misfolded proteins) → Client protein conformation is stabilized → In pathology (SCA3), the complex binds and stabilizes misfolded, polyQ-expanded ATXN3 → Degradation of mutant ATXN3 is inhibited → Cellular aggregation of mutant ATXN3 is increased."
      ],
      "specific_effects": [
        "The HSP90-Cdc37 complex utilizes ATP to promote and stabilize functional conformations of its client kinases.",
        "Pharmacological inhibition of HSP90 leads to the destabilization and subsequent proteasomal degradation of its client proteins.",
        "In a mouse model of SCA3, mutant ataxin-3 showed diminished interaction with a cluster of proteins including Hsp90aa1, suggesting the pathological polyQ tract alters these interactions."
      ],
      "evidence": [
        {
          "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
          "journal": "Frontiers in Molecular Neuroscience",
          "year": 2023,
          "relevant_quote": "The third set of proteins with diminished interaction with mutant ataxin-3 (150 CAG repeats) in the cerebral cortex is involved in mitochondrial transport. Two-sample t-test (p ≤ 0.05; *p < 0.05, **p < 0.01, ***p < 0.001); total number of biological replicates: n = 8, n = 4 per genotype; error bars: SEM. ... Hsp90aa1, Aifm1) (quantification: proteins pull-down and proteomics p < 0.05; two-sample t-test; STRING Network p < 10e-16; Figures 6E,F).",
          "pmid": "37033372"
        },
        {
          "paper_title": "Structure of an Hsp90-Cdc37-Cdk4 complex",
          "journal": "Science",
          "year": 2006,
          "relevant_quote": "Activation of many protein kinases depends on their interaction with the Hsp90 molecular chaperone system. Recruitment of protein kinase clients to the Hsp90 chaperone system is mediated by the co-chaperone adaptor protein Cdc37, which acts as a scaffold, simultaneously binding protein kinases and Hsp90.",
          "pmid": "16949366"
        }
      ],
      "pathway": {
        "name": "Protein Folding",
        "canonical_name": "Protein Folding",
        "ontology_id": "GO:0006457",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "37033372",
        "16949366"
      ],
      "interaction_effect": "activation",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation",
      "arrow_context": {
        "direct_from": null,
        "direct_arrow": "activates",
        "net_from": "ATXN3",
        "net_arrow": "activates",
        "mediator_chain": [],
        "is_indirect": true
      },
      "net_arrow": "activates",
      "direct_arrow": "activates",
      "net_effect": "activation",
      "direct_effect": "activation"
    }
  ],
  "arrow": "binds",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "binds"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The provided input correctly identifies a binding interaction but lacks mechanistic detail and primary evidence for a direct ATXN3-HSP90AA1 link. The interaction is primarily understood in the context of the larger HSP90-CDC37 chaperone complex, which ATXN3 interacts with. The functional consequence is the regulation of client protein stability, which can include mutant ATXN3 itself.",
  "mechanism": "ATXN3 interacts with the HSP90/CDC37 chaperone complex, a critical component of the cellular protein quality control system. This machinery is responsible for the proper folding, maturation, and stability of a wide array of client proteins, particularly protein kinases. The complex can either refold misfolded proteins or target them for proteasomal degradation.",
  "effect": "By binding to the HSP90/CDC37 complex, ATXN3 is linked to the core machinery governing protein homeostasis. In the context of polyglutamine diseases, this interaction is relevant as the HSP90 chaperone system is known to stabilize misfolded and aggregation-prone proteins, such as the mutant, polyQ-expanded form of ATXN3, thereby potentially hindering its clearance and promoting aggregation.",
  "summary": "ATXN3 interacts with HSP90AA1 to modulate chaperone-mediated protein stability, ultimately affecting cellular aggregation of mutant atxn3 is increased.",
  "evidence": [
    {
      "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
      "journal": "Frontiers in Molecular Neuroscience",
      "year": 2023,
      "relevant_quote": "The third set of proteins with diminished interaction with mutant ataxin-3 (150 CAG repeats) in the cerebral cortex is involved in mitochondrial transport. Two-sample t-test (p ≤ 0.05; *p < 0.05, **p < 0.01, ***p < 0.001); total number of biological replicates: n = 8, n = 4 per genotype; error bars: SEM. ... Hsp90aa1, Aifm1) (quantification: proteins pull-down and proteomics p < 0.05; two-sample t-test; STRING Network p < 10e-16; Figures 6E,F)."
    },
    {
      "paper_title": "Structure of an Hsp90-Cdc37-Cdk4 complex",
      "journal": "Science",
      "year": 2006,
      "relevant_quote": "Activation of many protein kinases depends on their interaction with the Hsp90 molecular chaperone system. Recruitment of protein kinase clients to the Hsp90 chaperone system is mediated by the co-chaperone adaptor protein Cdc37, which acts as a scaffold, simultaneously binding protein kinases and Hsp90."
    }
  ],
  "pathways": [
    {
      "name": "Protein Folding",
      "canonical_name": "Protein Folding",
      "ontology_id": "GO:0006457",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- HSP90AA1:",
  "protein_a": "ATXN3",
  "protein_b": "HSP90AA1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-07T22:39:21.564638Z",
  "last_updated": "2025-12-07T22:39:21.564638Z"
}